Showing 35,461 - 35,480 results of 72,923 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.39s Refine Results
  1. 35461
  2. 35462
  3. 35463
  4. 35464
  5. 35465
  6. 35466
  7. 35467
  8. 35468
  9. 35469
  10. 35470
  11. 35471

    <i>Cryptococcus neoformans</i> incubated for 8 days in hypoxia reactivated with pantothenic acid (PA) and culturable cells rewired in minimal medium (MM) dilutions. by Benjamin Hommel (523072)

    Published 2019
    “…Pantothenic acid significantly decreased the latency at a concentration of 1.25x10<sup>-2</sup> μM or more in 8D-HYPOx and to a lesser extend in STAT cells (* p<0.01). …”
  12. 35472
  13. 35473
  14. 35474
  15. 35475
  16. 35476
  17. 35477

    Plasma β-hydroxybutyrate level and its neuronal transporter increase with reproductive transition. by Fan Ding (302565)

    Published 2013
    “…MCT1 expression showed a trend towards increasing from 3 to 9 months of age and decreased afterwards in nonTg hippocampus. …”
  18. 35478

    Effect of diabetes and ischemic conditioning on glutamine synthetase activity. by Diego C. Fernandez (292999)

    Published 2013
    “…Data are mean ± SEM (n = 8 retinas/group). ** p<0.01 versus age-matched controls, a p<0.01 versus diabetic sham-treated eyes, by Tukey’s test. …”
  19. 35479

    UTX-1 is required for VPA action in <i>C. elegans</i> embryos and in human cells. by Rakel Brendsdal Forthun (121022)

    Published 2012
    “…<p><b>A</b>) Two <i>UTX</i> wild type cell lines (MV4-11 and NB4) as well as the <i>UTX</i> mutant cell line THP-1 were treated with 1 mM VPA for 48 hours and analyzed for H3K27me3 and H2BK120ac expression. The mean intensity on one representative Western blot was calculated and normalized to beta-actin. …”
  20. 35480

    Effects of icv Injections of Hypocretin-1 on Activity in Wild-Type Zebrafish versus <i>hcrtr<sup>168</sup></i> Mutants by Tohei Yokogawa (80527)

    Published 2007
    “…Note dose-dependent reduction of activity after 140- and 1,400-pmol injections, as observed after mammalian hypocretin-1. A dose-dependent significant decrease in locomotion was detected using multilinear analysis of variance with repeated measures with increasing hypocretin doses (<i>p</i> = 0.01) as grouping factors.…”